Hip Implants More Likely to Fail in Women, Study Says

xray of a woman with a hip implant

Hip implants in women have a 29 percent higher failure rate than in men, Medpage Today reported. Researchers at the Permanente Research Group in San Diego published the study in the February 2013 issue of JAMA Internal Medicine.

In the study, funded by the Food and Drug Administration (FDA), researchers gathered data over an average of three years from 35,140 patients who had a primary total hip replacement. Scientists found that the failure rate for women was 2.3 percent, compared with 1.9 percent for men, and there was a higher risk of aseptic failure than septic failure – failure that results from an infection.

According to researchers, one of the contributing factors for the higher failure rate may be the large size of most hip implants. Women had more trouble with femoral head sizes of 36mm or more, compared with men. Metal-on-metal implants also failed more often in women, and the risk of failure in women was double the risk for men. Higher device failures also mean higher rates of revision surgery.

Some critics of the study suggest that the findings are trivial, while others found the data helpful.

Doctors Weigh in On Study Results

Injured by complications related to hip replacements? Get a Free Case Review

Diana Zuckerman, PhD, of the National Research Center for Women and Families in Washington, told MedPage Today that women have few other options if they are already suffering from pain and limited mobility. What is needed, said Zuckerman, is “long-term comparative effectiveness research based on large sample sizes, indicating which total hip arthroplasty devices are less likely to fail in women and in men, with subgroup analyses based on age and other key patient traits, as well as key surgeon and hospital factors.”

Others like Dr. Glenn Don Wera of UH Medical Center in Cleveland say the study provides valuable data that helps doctors understand more about why hip implants fail in women. Factors like women’s smaller stature may figure into the results.

Aside from risk factor such as gender, studies were done on the risk of failure with certain types of implants. Overall, Johnson and Johnson’s DePuy ASR had the highest rate of failure of all implants in both men and women.

  •  
  •  
  •  
Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for seven years. She specializes in fluoroquinolone antibiotics, vaccines and products that affect women’s health such as Essure birth control, transvaginal mesh and talcum powder. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • American Medical Writers Association (AMWA) Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

3 Cited Research Articles

  1. Gever, J. (2013, February 18). Hip implants more likely to fail in women. MedPage Today. Retrieved from https://www.medpagetoday.com/Orthopedics/Orthopedics/37420
  2. Johnson, L. A. (2013, February 14). J&J again recalls thousands of faulty hip implants. U. S. News. Retrieved from http://www.usnews.com/news/business/articles/2013/02/14/report-jj-recalls-thousands-of-hip-implants-2
  3. Beasley, D. (2013, February 1). J&J metal hip failed because of toxic debris – expert at trial. Reuters. http://www.reuters.com/article/2013/02/01/us-jj-hip-trial-idUSBRE91019V20130201
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(855) 396-3709